US Bancorp’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $146K | Sell |
17,983
-1,773
| -9% | -$14.4K | ﹤0.01% | 2218 |
|
2025
Q1 | $155K | Buy |
19,756
+12,869
| +187% | +$101K | ﹤0.01% | 2159 |
|
2024
Q4 | $103K | Buy |
6,887
+6,615
| +2,432% | +$98.5K | ﹤0.01% | 2387 |
|
2024
Q3 | $4.16K | Sell |
272
-1,790
| -87% | -$27.4K | ﹤0.01% | 3619 |
|
2024
Q2 | $31.4K | Buy |
2,062
+1,353
| +191% | +$20.6K | ﹤0.01% | 2873 |
|
2024
Q1 | $13.4K | Sell |
709
-7,952
| -92% | -$150K | ﹤0.01% | 3224 |
|
2023
Q4 | $165K | Buy |
8,661
+6,751
| +353% | +$129K | ﹤0.01% | 2103 |
|
2023
Q3 | $34.3K | Sell |
1,910
-1
| -0.1% | -$18 | ﹤0.01% | 2620 |
|
2023
Q2 | $38.8K | Buy |
1,911
+536
| +39% | +$10.9K | ﹤0.01% | 2601 |
|
2023
Q1 | $25.1K | Buy |
1,375
+328
| +31% | +$5.98K | ﹤0.01% | 2866 |
|
2022
Q4 | $21.7K | Buy |
1,047
+547
| +109% | +$11.3K | ﹤0.01% | 2944 |
|
2022
Q3 | $13K | Buy |
500
+31
| +7% | +$806 | ﹤0.01% | 3265 |
|
2022
Q2 | $12K | Sell |
469
-99
| -17% | -$2.53K | ﹤0.01% | 3297 |
|
2022
Q1 | $18K | Buy |
568
+277
| +95% | +$8.78K | ﹤0.01% | 3128 |
|
2021
Q4 | $12K | Sell |
291
-252
| -46% | -$10.4K | ﹤0.01% | 3336 |
|
2021
Q3 | $19K | Buy |
543
+444
| +448% | +$15.5K | ﹤0.01% | 3140 |
|
2021
Q2 | $3K | Hold |
99
| – | – | ﹤0.01% | 3731 |
|
2021
Q1 | $3K | Hold |
99
| – | – | ﹤0.01% | 3603 |
|
2020
Q4 | $3K | Buy |
+99
| New | +$3K | ﹤0.01% | 3484 |
|
2020
Q3 | – | Sell |
-44
| Closed | -$1K | – | 3733 |
|
2020
Q2 | $1K | Buy |
+44
| New | +$1K | ﹤0.01% | 3556 |
|
2019
Q3 | – | Sell |
-2,891
| Closed | -$23K | – | 3657 |
|
2019
Q2 | $23K | Hold |
2,891
| – | – | ﹤0.01% | 2825 |
|
2019
Q1 | $36K | Buy |
2,891
+645
| +29% | +$8.03K | ﹤0.01% | 2637 |
|
2018
Q4 | $25K | Buy |
2,246
+120
| +6% | +$1.34K | ﹤0.01% | 2730 |
|
2018
Q3 | $30K | Buy |
+2,126
| New | +$30K | ﹤0.01% | 2784 |
|